News from Zentiva
September 20, 2024 / 2024
CPhI Worldwide Milan, come and visit us!
The global leader in pharmaceutical events - CPhI is returning to Milan for its upcoming edition in 2024.
From 8th to 10th October, Fiera Milano will host over 45 000 professionals against the backdrop of the most disruptive innovations in the pharmaceutical industry.
During the exhibition, a team from Zentiva will be present to discuss exciting new opportunities for working together on innovative pharma solutions. Please scroll down below to learn more or to contact us here!
The team of Zentiva including our B2B Unit - Zent2U and R&D - Prague Scientific is ready to introduce you to new opportunities to elevate your business, built on trusted partnerships.
We highly value our strategic partnerships in delivering on our purpose to provide health and wellbeing for all generations. We do that by ensuring the supply of high-quality and affordable medicines to millions of people who depend on them every day, in Europe and beyond.
We continue to expand into multiple new territories and enlarge our portfolio in key therapeutical areas, like cardiology and circulation, diabetes, oncology, respiratory, CNS and consumer healthcare.
Let's drive together growth in high-value segments for a healthy and sustainable tomorrow.
From 8th to 10th October, Fiera Milano will host over 45 000 professionals against the backdrop of the most disruptive innovations in the pharmaceutical industry.
During the exhibition, a team from Zentiva will be present to discuss exciting new opportunities for working together on innovative pharma solutions. Please scroll down below to learn more or to contact us here!
Connect with us!
Visit our experts at sustainable stand #10C17 in Hall 10 to discover our latest products, technologies, and services.The team of Zentiva including our B2B Unit - Zent2U and R&D - Prague Scientific is ready to introduce you to new opportunities to elevate your business, built on trusted partnerships.
We highly value our strategic partnerships in delivering on our purpose to provide health and wellbeing for all generations. We do that by ensuring the supply of high-quality and affordable medicines to millions of people who depend on them every day, in Europe and beyond.
We continue to expand into multiple new territories and enlarge our portfolio in key therapeutical areas, like cardiology and circulation, diabetes, oncology, respiratory, CNS and consumer healthcare.
Let's drive together growth in high-value segments for a healthy and sustainable tomorrow.